Wuhan Virus Vaccines and Intellectual Property

President Joe Biden (D) is looking at “waiving” the patents held by American pharmaceutical companies—Pfizer and Moderna—that  developed the vaccines that have been so effective against the Peoples Republic of China-released Wuhan Virus.

Leave aside the uselessness of waiving these patent rights because the vaccines require to much, too varied, too complex equipment to be manufacturable just on the basis of the vaccines’ technologies being made freeware in the public arena.

Leave aside, too, that these companies—and others beyond American jurisdiction that have developed other Wuhan Virus vaccines—already are delivering doses virtually at cost to the poorer nations.

Biden’s proposal [is] to temporarily waive their patents, but that’s completely disingenuous. An intellectual property once lost is lost forever—there is nothing temporary about such a waiver except in the narrowest, most legalist, sense.

The larger problem is the: with that government-mandated loss will go any incentive a company might have to spend the billions of dollars it takes to develop future such things, especially vaccines, since a company can have no confidence Government might decide it “needs” to give the new patents away also.

There will be very little vaccine development in the United States after Biden goes through with this.

This will not be over quickly. We will not enjoy this.

Leave a Reply

Your email address will not be published. Required fields are marked *